Seeking Alpha

Clinical Spotlight: Open-Label And Double-Blind Trials

Clinical trials are designed not just to test whether a treatment works, but to do so in a way that eliminates bias. Two common trial designs—open-label and double-blind—differ sharply in this ...
Seeking Alpha

Anavex: Understanding Their Alzheimer's Open-Label Extension Data Skeptically

On Saturday April 5, Anavex announced data from their open-label extension trial, ATTENTION-AD, for early Alzheimer's Disease presented at the AD/PDTM 2025 Conference. ATTENTION-AD is a follow-on ...
Nasdaq

Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025

Date and Time: Monday, November 3rd and Tuesday November 4th from 5:00- 7:00 PM ET Abstracts and additional details can be found at the CNS Summit 2025 website.
Stockhead on MSN

Alterity reports positive results from open-label phase II trial of neurological disease drug

Alterity Therapeutics reports positive topline results from open-label phase II clinical trial of lead drug ATH434 in multiple system atrophy. ... Read More The post Alterity reports positive results ...